New Perspectives in Attention Deficit Hyperactivity Disorder: Possible Link to Oxytocin by Mazlum Çöpür & Sidar Çöpür
New Perspectives in Attention Deficit 
Hyperactivity Disorder: Possible Link to Oxytocin
Mazlum Çöpür1, Sidar Çöpür2
1Department of Psychology, Arel University, Istanbul, Turkey,  2Department of Medicine, 
Koc University School of Medicine, Istanbul, Turkey
Letter to editor
Archives of Psychiatry Research 2021;57:199-202
DOI:10.20471/dec.2021.57.02.07
Received November 24, 2020, accepted after revision December 24, 2021
Correspodence to:
Mazlum Çöpür, MD
Department of Psychology, Arel 
University, Istanbul, Turkey
Phone: +90 505 335 11 62
E-mail: sidar1996@yahoo.com.tr
Dear Editor-in-chief, 
Attention deficit hyperactivity disorder 
(ADHD) is the most common neurobehav-
ioral disorder of  childhood and characterized 
by symptoms of  inattention, hyperactivity, im-
pulsivity and oppositional behaviors [1]. Al-
though the exact underlying pathophysiology 
of  ADHD remains unknown, multiple genetic 
and environmental factors including prenatal 
alcohol or tobacco exposure, structural brain 
disorders, mutations at dopaminergic and se-
rotonergic pathways, Turner syndrome, Tu-
berous Sclerosis Complex, Neurofibromatosis 
I and Fragile X syndrome have been implicated 
[2]. Obstetrical use of  oxytocin has been pro-
posed as potential risk factor in ADHD in few 
studies recently, however, a recent meta-analy-
sis study demonstrated no statistically signifi-
cant association [3]. Nevertheless, all studies 
conducted in this field are observational stud-
ies with low-to-middle scientific study quality 
and multiple interventional studies continue to 
be conducted.
As a nonapeptide, oxytocin, is primarily 
produced at paraventricular and supraoptic nu-
clei of  hypothalamus and released from poste-
rior pituitary gland. Predominant physiological 
functions include but not limited to childbirth 
and breastfeeding while additional roles in the 
field of  neuropsychiatry have recently been 
described [4]. Binding of  oxytocin to its’ re-
ceptor, a G-protein coupled receptor (specifi-
cally Gq type) through inositol triphosphate-
diacylglycerol (IP3-DAG) second messenger 
system, is involved in pain sensation integra-
tion, limbic system regulation, social learning 
and sensation [5,6]. Projections of  oxytocin-
producing cells towards gamma-aminobutyric 
acid (GABA)-secreting interneurons at amyg-
dala diminish output from amygdala which 
are crucial in emotions, social recognition 
and social learning [7,8]. Therefore, oxytocin 
signaling appears to modulate attention span 
and quality through limbic system, particularly 
amygdala [9]. Regarding its’ central role in neu-
rotransmission, oxytocin has been considered 
as novel therapeutic option for various neuro-
psychiatric disorders including major depres-
sion, postpartum depression, autism spectrum 
disorder, bipolar disorder and personality dis-
orders [10-14]. 
Lower plasma levels of  oxytocin have been 
recorded in patients with ADHD compared 
to controls [15,16]. In addition, lower levels 
of  oxytocin are demonstrated in ADHD pa-
tients who are not on medication compared to 
ADHD patients that are on medication while 
negative correlation between serum oxyto-
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cin levels and ADHD-Rating Scale scores has 
been reported in a study conducted with 36 
subjects with ADHD (23 non-medicated and 
13 medicated subjects) and 22 age and sex-
matched control subjects [15]. However, sig-
nificant variations in between ADHD patients 
in terms of  social skills, emotional control and 
social functioning are present which may be 
mainly due to different levels of  serum oxy-
tocin and genetic polymorphisms in oxytocin 
receptor gene. Higher serum levels of  oxyto-
cin are associated with better empathy skills, 
assessed via Bryant’s Empathy Index for Chil-
dren and Adolescents, and lower levels of  ag-
gression-impulsivity, assessed via Buss-Perry 
Aggression Questionnaire and Barratt impul-
sivity scale-11 in a study conducted with 40 
male ADHD patients at age 7-18 [17,18]. Mul-
tiple single nucleotide polymorphisms (SNP) 
at oxytocin receptor (OXTR) have been iden-
tified and associated with various phenotypes. 
For instance, SNP rs4686302 is associated 
with differences in social cognition while SNP 
rs53576-rs2254298 are linked to social deficits 
[19-21]. 
As evidences accumulating about the role 
of  oxytocin in ADHD, new therapeutic pos-
sibilities such as oxytocin administration and 
oxytocin receptor modulators have emerged. 
Commonly encountered adverse effects of  
intranasal oxytocin therapy in other fields are 
mild such as tiredness, nasal discomfort, diar-
rhea and skin irritation while severe side ef-
fects including seizures have rarely been re-
ported [22]. However, no randomized-control 
trial (RCT) has fully examined such therapeu-
tic approach yet while a double-blind placebo-
controlled cross-over RCT investigating the 
efficiency and safety of  intranasal oxytocin in 
adult patients with ADHD is registered and 
ongoing [23]. Even though the need for mul-
tiple large-scale RCT to evaluate the validity of  
oxytocin as a therapeutic option in ADHD is 
clear, it appears to be a promising therapeutic 
option that may influence future clinical prac-
tice
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